Navigation Links
At This Year's American Academy of AntiAging (A4M) Conference, Glycation and AGEs (Advanced Glycation End Products) Were Named the Leading Factors in Premature Aging and Disease
Date:5/3/2011

NEW YORK, May 3, 2011 /PRNewswire/ -- At this year's American Academy of AntiAging (A4M) conference, Glycation and AGEs (Advanced Glycation End Products) were named the leading factors in premature aging and disease. AGEs are dangerous substances that form in the blood as a result of sugar that attaches to a protein or lipid without the presence of an enzyme. And once formed, these AGEs are completely irreversible—and cause accelerated damage to the tissues and cells.

AGEs form at a constant slow rate in the normal body causing premature aging and disease over time.  However most current research reveals that their formation is even more accelerated in people with diabetes because of their sugar issues.  In fact, there is overwhelming evidence that confirms a link between AGEs and many diabetes complications including atherosclerosis, Heart Disease, retinopathy, neuropathy and nephropathy.

Atherosclerosis is responsible for more than forty percent of the deaths in this country and AGEs is the cause.   Today, more progressive doctors are considering anti-glycation as the best approach to stop the damaging effects of high blood sugar.  In addition to diabetes, studies have linked a high sugar intake with an increased risk of many health concerns, including cardiovascular disease, cancer, and erectile dysfunction.  Now we understand that this is due to glycation.  See studies below.

Sugar consumption then and now:  In the early 1800's the average sugar consumption was about 12 pounds per person annually. Today sugar consumption is rapidly approaching 200 pounds per year for one person. Those are very shocking numbers.  

Diabetes is reaching epidemic proportions:  Approximately 26 million Americans have diabetes and an additional 79 million Americans are estimated to have pre-diabetes.   Recently, the Centers for Disease Control and Pre
'/>"/>

SOURCE The Heart, Diabetes, and Weight Loss Centers of New York
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Thirty Years After 1st American "Test-Tube Baby," Economy May Be Biggest Obstacle for Infertile Couples
2. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
3. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
4. CAS Chemistry Research Report: 40 Years of Biofuel Research Reveal China Now Atop U.S. in Patenting and Commercialization of Bioethanol
5. $1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years
6. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
7. Lancaster Laboratories -- First Lab to be A2LA Accredited for 30 Consecutive Years
8. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
9. 40 Years on the Leading Edge: Case Western Reserve Universitys Biomedical Engineering Department Commemorates Achievement, Looks to Future
10. "Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila
11. A Worldwide Milestone in Cell Analysis - 40 Years of Flow Cytometry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery ... a Memorandum of Understanding with the Feinstein Institute ... New York to collaborate with the ... The collaboration brings together the drug ... clinical expertise of the Feinstein Institute in neurosciences ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 LC ... proteomics technologies, announced today that it is seeking ... an innovative multiplex PCR based targeted sequencing technology. ... sequence analysis, that enables accurate detection of rare ... and Omega-Primer™ technologies. The company will collaborate with ...
(Date:4/16/2015)... Spirax Sarco, the leader in ... newly designed, state-of-the-art website in the first quarter ... promotes the Spirax Sarco brand, company capabilities, and ... a site visitor might be looking for including ... serviced, the latest company news, careers, and much ...
(Date:4/16/2015)... 16, 2015 Cambridge Semantics ... driven by Semantic Web technology, and Informa ... and services for the academic and scientific, professional ... joint solution ‘Smart Data Lake for Clinical Trial ... the 2015 Bio-IT ‘Best of Show’ Award. ...
Breaking Biology Technology:Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Spirax Sarco website has a new look 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3
... centralised genotyping diagnostic service to facilitate the identification ... commercial poultry flocks. The test will allow ... two isolates and thus provide statistically significant evidence ... any such virus from a source flock to ...
... at 4:30pm ET European Commission Decision ... Company to Provide Update on FDA review of Qutenza ... - CHMP issued positive opinion recommending approval ... pain in non-diabetic adults, either alone or in combination ...
... 25 Percent to $62.6 Million -- Conference Call Today ... 7 PDL BioPharma, Inc. (PDL) (Nasdaq: ... quarter ended March 31, 2009. Total revenues from continuing ... million, a 25 percent increase from $50.2 million for ...
Cached Biology Technology:Avian Adenovirus Genotyping Diagnostic Service 2NeurogesX Reports First Quarter 2009 Results 2NeurogesX Reports First Quarter 2009 Results 3NeurogesX Reports First Quarter 2009 Results 4NeurogesX Reports First Quarter 2009 Results 5NeurogesX Reports First Quarter 2009 Results 6NeurogesX Reports First Quarter 2009 Results 7NeurogesX Reports First Quarter 2009 Results 8NeurogesX Reports First Quarter 2009 Results 9NeurogesX Reports First Quarter 2009 Results 10NeurogesX Reports First Quarter 2009 Results 11PDL BioPharma Announces First Quarter 2009 Financial Results 2PDL BioPharma Announces First Quarter 2009 Financial Results 3PDL BioPharma Announces First Quarter 2009 Financial Results 4PDL BioPharma Announces First Quarter 2009 Financial Results 5PDL BioPharma Announces First Quarter 2009 Financial Results 6PDL BioPharma Announces First Quarter 2009 Financial Results 7PDL BioPharma Announces First Quarter 2009 Financial Results 8PDL BioPharma Announces First Quarter 2009 Financial Results 9
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Council (MRC) have discovered for the first time that two ... helping to identify how the body,s own cells fight back ... open-access journal PLoS Biology , could lead to future ... cells, an entirely new concept for cancer research. The ...
... Jay Kolls, Professor and Chairman of Genetics at the LSU ... awarded a $2.1 million grant over five years by the ... of Health to determine the role and identify which T-helper ... (PCP), which can be a complication of HIV/AIDS. It can ...
... Spanish . , A new beetle that could be ... identified by Agricultural Research Service (ARS) scientists and cooperators. ... Thailand by entomologists Bob Pemberton (now retired), with the ARS ... Wright, with the ARS Australian Biological Control Laboratory (ABCL) in ...
Cached Biology News:Divide and conquer: Genes decide who wins in the body's battle against cancer 2LSUHSC awarded $2 million dollar grant to prevent pneumonia linked to immune deficiency 2Scientists identify new potential biocontrol for skunk vine 2